Among patients with prostate cancer, a high omega-3, low-omega-6 diet with fish oil led to a Ki-67 index decrease.

New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...

Despite guidelines addressing overdetection, no significant declines are seen; emphasis on active surveillance approaches is ...

After re-staging patients, ideally with PSMA-PET, and performing a biopsy to confirm the recurrence and stratify them into risk categories, it is time to discuss local salvage treatment. Options ...

Artera and Tempus are collaborating to expand access to Artera’s AI-based prostate cancer test. Currently connected to more ...

In the post-op SAKK 09/10 trial, only patients in the higher PORTOS score group benefited from radiation therapy dose escalation (clinical progression free survival HR 0.19, 95% CI 0.05-0.70; p = 0.01 ...

Among those with intermediate-risk prostate cancer, high PSA levels prior to HIFU led to an increased risk of overall ...

PORTOS can determine which patients with localized prostate cancer will benefit from dose-escalation of radiotherapy, data suggest.

Robotic bronchoscopy can help diagnose spots in the lungs when they are still small, catching cancer sooner and saving many ...

The 18-gene MyProstateScore 2.0 (MPS2) test using first-catch non-digital rectal examination (DRE) urine is highly se ...

This interview has been edited for length and clarity.

DuBois, Pennsylvania, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Lung cancer is a source of more cancer deaths in the U.S. than breast, colon and prostate cancer combined. People diagnosed with lung cancer are ...